Additional studies assessing IgM antibodies towards different OSE, and in particular the P1 mimotope, in multiple larger cohorts are necessary to confirm the inverse correlation with NAFLD and to address the potential causal link with obesity. This evidence concerns the gene CD40LG and metabolic dysfunction-associated steatotic liver disease.